United Arab Emirates (UAE) reviews antenatal testing provision:
This article was originally published in Clinica
The United Arab Emirates government is reviewing its primary healthcare provision, particularly in the area of antenatal testing. Testing for phenylketonuria has been available routinely to all neonates in the UAE's maternal and child health centres since last year. Hypothyroidism testing will be introduced shortly, paediatric consultant Dr Lana Badreddin told the Khaleej Times. Dr Badreddin is calling for standardisation of diagnostic testing during pregnancy, particularly of ultrasound scans.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.